| ISIN | CH0594527720 |
|---|---|
| Valor Number | 59452772 |
| Bloomberg Global ID | UBPAIIX SW |
| Fund Name | UBS (CH) Investment Fund - Equities Switzerland ESG Passive All II I-X-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 |
| Asset Class | Bonds |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Das Anlageziel dieses Teilvermögens besteht hauptsächlich darin, den repräsentativen Referenzindex SPI® ESG (TR) für den schweizerischen Aktienmarkt (Bench-mark) passiv nachzubilden und eine Performance zu erzielen, welche dessen Entwicklung entspricht. |
| Peculiarities |
| Current Price * | 1,286.64 CHF | 15.12.2025 |
|---|---|---|
| Previous Price * | 1,272.92 CHF | 12.12.2025 |
| 52 Week High * | 1,286.64 CHF | 15.12.2025 |
| 52 Week Low * | 1,051.39 CHF | 09.04.2025 |
| NAV * | 1,286.64 CHF | 15.12.2025 |
| Issue Price * | 1,286.64 CHF | 15.12.2025 |
| Redemption Price * | 1,286.64 CHF | 15.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 2,632,588,741 | |
| Unit/Share Assets *** | 2,134,319,769 | |
| Trading Information SIX | ||
| YTD Performance | +15.61% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
|---|---|---|
| 1 month | +3.34% |
17.11.2025 - 15.12.2025
17.11.2025 15.12.2025 |
| 3 months | +6.31% |
15.09.2025 - 15.12.2025
15.09.2025 15.12.2025 |
| 6 months | +7.17% |
16.06.2025 - 15.12.2025
16.06.2025 15.12.2025 |
| 1 year | +14.81% |
16.12.2024 - 15.12.2025
16.12.2024 15.12.2025 |
| 2 years | +21.61% |
15.12.2023 - 15.12.2025
15.12.2023 15.12.2025 |
| 3 years | +28.86% |
15.12.2022 - 15.12.2025
15.12.2022 15.12.2025 |
| 5 years | +34.67% |
11.02.2021 - 15.12.2025
11.02.2021 15.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 13.07% | |
|---|---|---|
| Nestle SA | 12.45% | |
| Novartis AG Registered Shares | 12.42% | |
| UBS Group AG Registered Shares | 5.59% | |
| Compagnie Financiere Richemont SA Class A | 5.54% | |
| ABB Ltd | 5.51% | |
| Zurich Insurance Group AG | 5.11% | |
| Swiss Re AG | 2.56% | |
| Holcim Ltd | 2.41% | |
| Lonza Group Ltd | 2.34% | |
| Last data update | 30.11.2025 | |
| TER | 0.01% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.01% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |